Rowbotham N - Search Results

1

Retrospective review of treatment outcomes and costs in children with sleep disordered breathing assessed with multi-channel studies.

Yanney M, Rowbotham N, Ng C, Zulkifli M, Shehata A, Chidambaram A, Tsirevelou P, Fergie N, Thakkar P, Crookes E, Dean R, Prayle A. Yanney M, et al. Among authors: rowbotham n. Sleep Med X. 2024 May 6;7:100115. doi: 10.1016/j.sleepx.2024.100115. eCollection 2024 Dec. Sleep Med X. 2024. PMID: 39022329 Free PMC article.

2

Prospective evaluation of the impact of multi-channel studies on treatment outcomes in children with sleep disordered breathing.

Yanney M, Rowbotham N, Ng C, Zulkifli M, Shehata A, Chidambaram A, Tsirevelou P, Fergie N, Thakkar P, Crookes E, Dean R, Prayle A. Yanney M, et al. Among authors: rowbotham n. Sleep Med X. 2024 Apr 18;7:100111. doi: 10.1016/j.sleepx.2024.100111. eCollection 2024 Dec. Sleep Med X. 2024. PMID: 38800098 Free PMC article.

3

Infection prevention and control in cystic fibrosis: An update of a systematic review of interventions.

Rowbotham NJ, Smith S, Jahnke N, Milczanowski S, Elliott ZC, Prayle AP, Smyth AR. Rowbotham NJ, et al. J Cyst Fibros. 2024 Aug 27:S1569-1993(24)00830-0. doi: 10.1016/j.jcf.2024.08.004. Online ahead of print. J Cyst Fibros. 2024. PMID: 39198075 Free article.

4

A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator era.

Calthorpe RJ, Goodchild N, Gleetus V, Premakumar V, Hayee B, Elliott Z, Evans B, Rowbotham NJ, Carr SB, Barr H, Horsley A, Peckham D, Smyth AR. Calthorpe RJ, et al. Among authors: rowbotham nj. NIHR Open Res. 2024 Feb 5;3:18. doi: 10.3310/nihropenres.13384.1. eCollection 2023. NIHR Open Res. 2024. PMID: 37881465 Free PMC article.

5

A refresh of the top 10 research priorities in cystic fibrosis.

Rowbotham NJ, Smith S, Elliott ZC, Cupid B, Allen LJ, Cowan K, Allen L, Smyth AR. Rowbotham NJ, et al. Thorax. 2023 Aug;78(8):840-843. doi: 10.1136/thorax-2023-220100. Epub 2023 Jun 7. Thorax. 2023. PMID: 37286236 Free PMC article.

6

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Langton Hewer SC, Smith S, Rowbotham NJ, Yule A, Smyth AR. Langton Hewer SC, et al. Among authors: rowbotham nj. Cochrane Database Syst Rev. 2023 Jun 2;6(6):CD004197. doi: 10.1002/14651858.CD004197.pub6. Cochrane Database Syst Rev. 2023. PMID: 37268599 Free PMC article. Review.

7

Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.

Smith S, Rowbotham NJ. Smith S, et al. Among authors: rowbotham nj. Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD001021. doi: 10.1002/14651858.CD001021.pub4. Cochrane Database Syst Rev. 2022. PMID: 36373968 Free PMC article. Review.

8

Industry influence in healthcare harms patients: myth or maxim?

Trayer J, Rowbotham NJ, Boyle RJ, Smyth AR. Trayer J, et al. Among authors: rowbotham nj. Breathe (Sheff). 2022 Jun;18(2):220010. doi: 10.1183/20734735.0010-2022. Epub 2022 Jul 12. Breathe (Sheff). 2022. PMID: 36337122 Free PMC article. Review.

9

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.

Smith S, Rowbotham NJ, Charbek E. Smith S, et al. Among authors: rowbotham nj. Cochrane Database Syst Rev. 2022 Aug 1;8(8):CD008319. doi: 10.1002/14651858.CD008319.pub4. Cochrane Database Syst Rev. 2022. PMID: 35914011 Free PMC article. Review.

10

Short-acting inhaled bronchodilators for cystic fibrosis.

Smith S, Rowbotham NJ, Edwards CT. Smith S, et al. Among authors: rowbotham nj. Cochrane Database Syst Rev. 2022 Jun 24;6(6):CD013666. doi: 10.1002/14651858.CD013666.pub2. Cochrane Database Syst Rev. 2022. PMID: 35749226 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters